ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0179

Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine Learning

Bryant England1, Yangyuna Yang1, Punyasha Roul1, Christian Haas2, Lotfollah Najjar2, Harlan Sayles1, Fang Yu1, Brian Sauer3, Joshua Baker4, Kaleb Michaud1, Fenglong Xie5, Jeffrey R Curtis6 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Omaha, Omaha, NE, 3University of Utah, Omaha, NE, 4University of Pennsylvania, Philadelphia, PA, 5University of Alabama at Birmingham, Birmingham, AL, 6Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR Convergence 2020

Keywords: Administrative Data, Comorbidity, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Multimorbidity

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Chronic conditions often complicate the disease course of rheumatoid arthritis (RA) and predispose to poor long-term outcomes. The interrelationship of individual chronic conditions and their contribution to the overall burden of multimorbidity afflicting patients with RA is not well understood. We aimed to identify patterns of multimorbidity in RA using unsupervised machine learning.

Methods: We constructed RA and age-, sex-, and year-matched (1:1) non-RA cohorts within a large commercial insurance database (MarketScan, 2006-2015) and the Veterans Health Administration (VHA, 2001-2015) using validated administrative algorithms for RA. Chronic conditions (n=44, selected based on relevance to multimorbidity in the general population and RA) were identified using diagnosis codes from outpatient and inpatient encounters. Unsupervised machine learning was conducted separately in both databases and stratified by RA status and sex, to identify patterns of multimorbidity. Tetrachoric correlation coefficients were calculated between pairs of chronic conditions. Factor analysis was performed on this correlation matrix using the principal factor method. Factors with Eigenvalues ³1 were retained and an orthogonal rotation was executed on the extracted factors. Conditions with a factor loading >0.3 were considered relevant to the extracted factor, and patients were considered to have the multimorbidity pattern specified by that factor if they had at least 2 conditions with factor loadings >0.3 for that factor. The prevalence of the derived multimorbidity patterns was compared between RA and non-RA patients using conditional logistic regression.

Results: We studied 226,850 patients in MarketScan (76% female, mean age 53 [female] and 58 [male] years) and 120,780 patients in the VHA (89% male, mean age 53 [female] and 64 [male] years). In both MarketScan (Table 1) and the VHA (Table 2), cardiovascular, metabolic, cardiopulmonary, mental health, and pain disorders were the primary patterns of multimorbidity identified in RA and non-RA populations. Similar multimorbidity patterns were also derived separately in men and women. The frequency of each multimorbidity pattern was significantly higher in RA (odds ratios ranging from 1.17 to 2.96), with cardiopulmonary, mental health, and pain disorder related multimorbidity patterns most closely associated with RA (Table 3).

Conclusion: Using two independent, large, real-world datasets and unsupervised machine learning, we identified cardiometabolic, cardiopulmonary, and mental health/pain disorders as the predominant patterns of multimorbidity in RA. Patterns of multimorbidity are similar between RA and non-RA populations, suggesting the interrelationships of chronic conditions is similar in RA as in the general population. However, because the prevalence of these overlapping disease processes is significantly higher in RA, it is imperative for clinicians to recognize and address these patterns of multimorbidity to achieve optimal long-term outcomes for patients with RA.

Table 1. Multimorbidity patterns identified through factor analysis within MarketScan

Table 2. Multimorbidity patterns identified through factor analysis within the Veterans Health Administration

Table 3. Prevalence of multimorbidity patterns in RA and non-RA patients


Disclosure: B. England, None; Y. Yang, None; P. Roul, None; C. Haas, None; L. Najjar, None; H. Sayles, None; F. Yu, None; B. Sauer, None; J. Baker, None; K. Michaud, Rheumatology Research Foundation, 2; F. Xie, None; J. Curtis, AbbVie, 2, 5, Amgen, 2, 5, Bristol-Myers Squibb, 2, 5, Corrona, 2, 5, Janssen, 2, 5, Lilly, 2, 5, Myriad, 2, 5, Pfizer, 2, 5, Regeneron, 2, 5, Roche, 2, 5, UCB, 2, 5, Gilead Sciences, Inc., 5, Sanofi, 5; T. Mikuls, Horizon Therapeutics, 2.

To cite this abstract in AMA style:

England B, Yang Y, Roul P, Haas C, Najjar L, Sayles H, Yu F, Sauer B, Baker J, Michaud K, Xie F, Curtis J, Mikuls T. Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine Learning [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/identification-of-multimorbidity-patterns-in-rheumatoid-arthritis-through-machine-learning/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-multimorbidity-patterns-in-rheumatoid-arthritis-through-machine-learning/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology